Human IgG2 Isotype Control antibody (HyHEL-10)

Description of Human IgG2 Isotype Control antibody (HyHEL-10)

Introduction

Human IgG2 Isotype Control antibody (HyHEL-10) is a monoclonal antibody that has been extensively used in research and clinical settings as a control for IgG2 antibodies. This antibody is produced by the HyHEL-10 hybridoma cell line and has been widely used as a therapeutic target and research tool due to its unique structure and activity.

Structure of Human IgG2 Isotype Control antibody (HyHEL-10)

Human IgG2 Isotype Control antibody (HyHEL-10) belongs to the immunoglobulin G (IgG) class of antibodies and is composed of two heavy chains and two light chains. Each heavy chain contains four constant domains (CH1-CH4) and one variable domain (VH), while each light chain contains one variable domain (VL) and one constant domain (CL). The HyHEL-10 antibody specifically binds to the constant region of the IgG2 isotype, making it a suitable control for IgG2 antibodies.

Activity of Human IgG2 Isotype Control antibody (HyHEL-10)

The main function of Human IgG2 Isotype Control antibody (HyHEL-10) is to serve as a control for IgG2 antibodies. This means that it does not bind to any specific antigen, but rather serves as a reference point for the activity of IgG2 antibodies. The HyHEL-10 antibody is able to bind to the constant region of IgG2 antibodies, preventing them from binding to their target antigen. This allows researchers to accurately assess the activity of IgG2 antibodies in various experiments.

Application of Human IgG2 Isotype Control antibody (HyHEL-10)

Human IgG2 Isotype Control antibody (HyHEL-10) has a wide range of applications in both research and clinical settings. Some of the key applications include:

Therapeutic Target

The unique structure and activity of Human IgG2 Isotype Control antibody (HyHEL-10) make it a potential therapeutic target for various diseases. For example, in autoimmune diseases where IgG2 antibodies are overproduced, the HyHEL-10 antibody can be used to inhibit their activity and reduce the symptoms of the disease.

Research Use

Human IgG2 Isotype Control antibody (HyHEL-10) is widely used in research to study the activity and function of IgG2 antibodies. It is commonly used as a control in experiments involving IgG2 antibodies, such as ELISA, western blotting, and flow cytometry. The HyHEL-10 antibody allows researchers to accurately assess the activity of IgG2 antibodies and compare it to other isotypes.

Diagnostic Tool

In addition to its research applications, Human IgG2 Isotype Control antibody (HyHEL-10) can also be used as a diagnostic tool. It can be used in diagnostic tests to detect the presence of IgG2 antibodies in patient samples, which can help in the diagnosis and monitoring of certain diseases.

Therapeutic Antibody Development

The HyHEL-10 antibody can also be used in the development of therapeutic antibodies. By understanding its structure and activity, researchers can use this information to design and develop more effective therapeutic antibodies that target the IgG2 isotype.

Conclusion

In conclusion, Human IgG2 Isotype Control antibody (HyHEL-10) is a valuable tool in both research and clinical settings. Its unique structure and activity make it a suitable control for IgG2 antibodies, allowing for accurate assessment of their activity. With its potential as a therapeutic target and its various applications, the HyHEL-10 antibody continues to be an important tool in the field of immunology.